Nyxoah (NYXH) Begins BREATHE Study. Can Real-World Evidence Drive Genio Adoption?
Nyxoah SA (NASDAQ:NYXH) announced the first patient implantation in BREATHE on September 7. The prospective, single-arm U.S.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 14,632,880 | $20,193,374 | +1% | 2.04% |
| 2. | Syquant Capital Olivier Leymarie And Henri Jeantet | 596,393 | $757 | 0.17% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 714,141 | $991,103 | 0.08% | |
| 2. | 522,057 | $720,439 | 0.41% | |
| 3. | 252,930 | $350,958 | 0.02% | |
| 4. | 119,632 | $165,092 | 0% | |
| 5. | 79,237 | $109,347 | 0% |